International Benchmark Values for Robotic Right Hepatectomy: Multicenter Study From 22 Expert Centers
作者:Philip C. Müller, Noa L E Aegerter, Adrian T. Billeter, Janina Eden, Beat Moeckli, Charles Chung-Wei Lin, Yuta Abe, Yutaka Nakano, Roberta Odorizzi, Mafalda Sobral, Florian Primavesi, Stefan Stättner, R Robles, Víctor López‐López, Cristiano Guidetti, Fabrizio Di Benedetto, Schaima Abdelhadi, Christoph Reißfelder, Raphael L. C. Araújo, John B. Martinie, Riccardo Memeo, Antonella Delvecchio, Christoph Tschuor, Daisuke Fukumori, Mathieu D’Hondt, Taiga Wakabayashi, Go Wakabayashi, Andrea Lauterio, Leonardo Centonze, Gi Hong Choi, Gabriela Pilz da Cunha, Rutger‐Jan Swijnenburg, Philipp H. von Kroge, Asmus Heumann, Shadi Katou, Benjamin Struecker, Andreas Pascher, Zhihao Li, Mohammad Abu Hilal, Soufyan el Adel, Simon Störzer, Moritz Schmelzle, Juba Ait Mohand, Mickaël Lesurtel, Sarkis Drejian, Åsmund Avdem Fretland, Bjørn Edwin, Michael Ginesini, Ugo Boggi, Gianluca Rompianesi, Roberto Troisi, Mirhasan Rahimli, Roland S. Croner, Christian Toso, Tomoaki Kato, Jason Hawksworth, Hugo P. Marques, Iswanto Sucandy, Philipp Dutkowski, Christoph Kuemmerli, Beat P. Müller‐Stich · 发表于:Annals of Surgery Open · 年份:2025 · DOI:10.1097/as9.0000000000000625 · 被引用次数:5 · 研究领域:Hepatocellular Carcinoma Treatment and Prognosis、Organ Transplantation Techniques and Outcomes、Cholangiocarcinoma and Gallbladder Cancer Studies
Objective: This study aimed to identify benchmark values for robotic right hepatectomy (RH) based on a low-risk cohort treated at expert centers. Background: Robotic liver surgery is emerging as a preferred minimally invasive approach to the liver. To enable conclusive comparisons with the standard open or laparoscopic approaches, reference values are needed. Methods: Outcomes from consecutive patients undergoing robotic RH for malignant or benign indications at 22 international expert centers between 2018 and 2024 were analyzed. Low-risk, benchmark patients were without significant comorbidities such as portal hypertension, Child B cirrhosis, cardiac disease, chronic pulmonary disease, and renal failure. Patients undergoing robotic RH for donor hepatectomy were excluded. Fifteen reference values were derived from the 75th or the 25th percentile of the median values of all centers. Reference values were compared with a laparoscopic cohort from 4 centers and published benchmark values for laparoscopic and open RH. Results: Of 357 patients, 172 (48%) qualified as the benchmark cohort. The main indications were hepatocellular carcinoma (31%) and colorectal liver metastases (27%). Reference values included: operative time (≤476 min), conversion rate (≤8.2%), bile leak (≤15.4%), major complications (≤23.1%), and comprehensive complication index at 90 days (≤15.6). Robotic RH compared favorably to a multinational cohort series of laparoscopic RH with lower conversion (10.0% vs ≤8.2...